Multifunctional microcapsules: A theranostic agent for US/MR/PAT multi-modality imaging and synergistic chemo-photothermal osteosarcoma therapy

Hufei Wang,Sijia Xu,Daoyang Fan,Xiaowen Geng,Guang Zhi,Decheng Wu,Hong Shen,Fei Yang,Xiao Zhou,Xing Wang
DOI: https://doi.org/10.1016/j.bioactmat.2021.05.004
IF: 18.9
2022-01-01
Bioactive Materials
Abstract:A facile and efficient premix membrane emulsification method to prepare multifunctional theranostic agents.These MCs possess excellent US/MR/PAT multi-modality imaging performance.These MCs achieve the synergistic therapeutic outcomes of chemotherapy and photothermal therapy in response to NIR stimuli.A combined effect of magnetic targeting and chemo-photothermal osteosarcoma therapy with prominent anticancer efficacy.Development of versatile theranostic agents that simultaneously integrate therapeutic and diagnostic features remains a clinical urgent. Herein, we aimed to prepare uniform PEGylated (lactic-co-glycolic acid) (PLGA) microcapsules ((Fe<sub>3</sub>O<sub>4</sub>@PEG-PLGA) MCs) with superparamagnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles embedded in the shell and Prussian blue (PB) NPs inbuilt in the cavity via a premix membrane emulsification (PME) method. On account of the eligible geometry and multiple load capacity, these MCs could be used as efficient multi-modality contrast agents to simultaneously enhance the contrasts of US, MR and PAT imaging. In-built PB NPs furnished the MCs with excellent photothermal conversion property and embedded Fe<sub>3</sub>O<sub>4</sub> NPs endowed the magnetic location for fabrication of targeted drug delivery system. Notably, after further in-situ encapsulation of antitumor drug of DOX, (PB+DOX)@(Fe<sub>3</sub>O<sub>4</sub>@PEG-PLGA) MCs possessed more unique advantages on achieving near infrared (NIR)-responsive drug delivery and magnetic-guided chemo-photothermal synergistic osteosarcoma therapy. <em>In vitro</em> and <em>in vivo</em> studies revealed these biocompatible (PB+DOX)@(Fe<sub>3</sub>O<sub>4</sub>@PEG-PLGA) MCs could effectively target to the tumor tissue with superior therapeutic effect against the invasion of osteosarcoma and alleviation of osteolytic lesions, which will be developed as a smart platform integrating multi-modality imaging capabilities and synergistic effect with high therapy efficacy.Schematic illustration of a theranostic agent of (PB+DOX)@(Fe<sub>3</sub>O<sub>4</sub>@PEG-PLGA) MCs towards multi-modality imaging, magnetic targeting ability and NIR-triggered chemo-photothermal osteosarcoma therapy.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21002243-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (532KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21002243-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?